Health
We’re booking some profits on this health insurance stock after waiting out its slump
It’s taken some patience. But shares of this company finally broke through $500 each in Friday trading, so we’re ringing the register. Source
Read More
JPMorgan says this controversial eye disease treatment can more than double this biopharma stock
A controversial eye treatment from Apellis can lead to sharp returns for investors, according to JPMorgan. The bank upgraded the biopharmaceutical stock to overweight from neutral and raised its price target to $81 from $60. JPMorgan’s news forecast implies more than 104% upside from Thursday’s $39.64 close. Shares of Apellis are down over 23% since […]
Read More
Philips shares fall 8% after U.S. drug regulator deals fresh blow to sleep device recall
Philips office building in Warsaw, Poland on July 29, 2021. (Photo by Beata Zawrzel/NurPhoto via Getty Images) Nurphoto | Nurphoto | Getty Images Shares of Dutch health tech company Philips tumbled to the bottom of the European benchmark on Friday, after the U.S. drug regulator deemed its handling of a major product recall inadequate. The […]
Read More
Do menopause retreats work — and why are people paying $15,000 for them?
Belly dancing, yoga in the forest, traditional Chinese medicine and meetings with a nutritionist. These are some of the activities that can be found at menopause retreats, a wellness trend carving a new niche in the tourism industry. Menopause retreats are tailored to help women navigate the different stages of perimenopause and menopause, and the […]
Read More
Kaiser Permanente workers strike for second day after negotiations fail to reach labor contract
Kaiser Permanente employees, joined by Union members representing the workers, walk the picket line in Los Angeles, California on October 4, 2023. Frederic J. Brown | AFP | Getty Images Tens of thousands of Kaiser Permanente workers remained on strike for a second day after negotiators failed to reach an agreement to end a dispute […]
Read More
Weight loss drugs may be linked to stomach paralysis, other rare but severe issues, study says
Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity. Michael Siluk | UCG | Getty Images Blockbuster weight loss and diabetes drugs like Wegovy and Ozempic may be associated with an increased risk of three rare, […]
Read More
Neuralink competitor Precision Neuroscience buys factory to build its brain implants
Employees working in Precision’s manufacturing facility Courtesy: Precision Neuroscience Neurotech startup Precision Neuroscience announced Thursday it has acquired a factory in Dallas, where it will build the key component of its brain implant, the Layer 7 Cortical Interface. The facility will help the company speed up development and move closer to the regulatory approval it […]
Read More
Lab owner who defrauded Medicare to forfeit $187 million, Ferrari
Exhibit from court record: 2018 Red Ferrari Spider. Source: U.S. DOJ A Miami federal judge ordered a lab owner convicted of defrauding Medicare to forfeit more than $187 million worth of proceeds from the scam, including $30 million in cash, a 2018 Ferrari Spider and real estate, the Department of Justice said Wednesday. The lab […]
Read More
More than 75,000 workers to strike at hundreds of Kaiser Permanente health facilities across U.S.
A Kaiser Permanente health care center is pictured in Anaheim, California, U.S., October 3, 2023 as more than 75,000 Kaiser Permanente healthcare workers could go on strike from Oct. 4 to Oct. 7 across the United States. Mike Blake | Reuters Workers at Kaiser Permanente — the nation’s largest health-care nonprofit organization — began a […]
Read More
Moderna combination Covid, flu vaccine moves to final stage trial after positive data
Artur Widak | Nurphoto | Getty Images Moderna on Wednesday said its combination vaccine targeting Covid and the flu will move to a final stage trial in adults ages 50 and above this year after showing positive results in an early to mid-stage study. The biotech company hopes its shot, mRNA-1083, can win approval from […]
Read More